NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuroQuest

NeuroQuest

Private
IsraelHealthcare & Life Scienceshttps://www.neuroquest.co/

Last Round

VC Round

May 15, 2025

Total Funding Raised

$500,000

Company Overview

NeuroQuest is a biotechnology company that develops blood-based diagnostic tools for the early detection of neurodegenerative diseases such as Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

Alzheimer's diagnosticsblood-based diagnosticbiomarker testingamyloid-beta detectionearly detectionliquid biopsyprecision medicinediagnostic assayclinical validationAI diagnosticsdigital biomarkerneurodegenerative screeningbiotech R&Dmedical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroQuest Comparables

Compare NeuroQuest with similar companies based on industry and business-model similarity.

NeuroQuest comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
C2N Diagnostics
85%
ADmit Therapeutics
81%
ALZpath, Inc.
78%

NeuroQuest Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 15, 2025
SeedMay 14, 2013
SeedDec 17, 2012
AcceleratorJan 1, 2008

Key People

Founding team and executive leadership

Mike Astle

Chief Technology Officer

Executive Team

NeuroQuest Investors

Notable investors and investment history

NeuroQuest investors
InvestorRounds
Israel Innovation AuthorityAccelerator
SC LaunchVC Round
The Trendlines GroupAccelerator, Seed
SCRASeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Grew 44% QoQ from 9 to 13 employees.

  • Jan 21, 2026

    Grew 30% QoQ, from 10 to 13 employees.

NeuroQuest Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroQuest Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroQuest's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range13
Year Founded2008
Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.